MoneyWorks4Me

Manipal Health gains on signing BTA to acquire Kinder Women’s Hospital in Bengaluru

18 Aug 2026 Evaluate

Manipal Health Enterprises is currently trading at Rs. 732.50, up by 10.80 points or 1.50% from its previous closing of Rs. 721.70 on the BSE.

The scrip opened at Rs. 724.25 and has touched a high and low of Rs. 738.00 and Rs. 724.25 respectively. So far 39334 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 2 has touched a 52 week high of Rs. 738.00 on 17-Aug-2026 and a 52 week low of Rs. 626.00 on 06-Aug-2026.

Last one week high and low of the scrip stood at Rs. 738.00 and Rs. 675.40 respectively. The current market cap of the company is Rs. 96594.72 crore.

The promoters holding in the company stood at 72.08%, while Institutions and Non-Institutions held 9.11% and 18.81% respectively.

Manipal Health Enterprises has signed Business Transfer Agreement (BTA) with Kindorama Healthcare (Seller) on August 17, 2026, for acquiring the entire operations of the Kinder Women’s Hospital and Fertility Centre, situated in Doddanekundi Industrial Area, Bengaluru, Karnataka.

The acquisition is allied to the current business and would result in growth opportunities in line with the strategic directions of the company. The acquisition cost is Rs 130 crore, and the acquisition shall be completed within 90 days from the date of execution.

Manipal Health Enterprises operates a pan India network of multispecialty hospitals delivering a comprehensive range of care services - from outpatient services to complex tertiary and quaternary interventions.

Manipal Health Enter Share Price

724.25 -20.30 (-2.73%)
20-Aug-2026 16:59 View Price Chart
Peers

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: